Biotech entity
pharma is the sole category represented across all 1 tracked stories. Joenja is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.
Last mentioned: Mar 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Joenja is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline. We currently track 1 Biotech story that mention Pharming Group N.V., all published on March 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pharming Group N.V.. Shared-story counts are live from our verified record — not editorial picks.
Pharming Group NV has exceeded top-line revenue expectations for the recent period while providing a robust financial roadmap through 2026. The company’s performance underscores the successful commercialization of its rare disease portfolio, contrasting with broader market volatility.
Pharming Group N.V. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
